| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |